Charlotte L B M Korst

9PUBLICATIONS
35CO-AUTHORS
Gene and molecular therapyHaematological tumoursMedical mycologyMolecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 08, 2026
Dual targeting of BCMA and GPRC5D with the trispecific antibody ramantamig addresses antigenic heterogeneity in myeloma.

|Sep 01, 2026
Spatial profiling identifies a distinct and topographically-defined tumor microenvironment that emerges during multiple myeloma evolution.

|Apr 20, 2026
Monocyte-mediated metabolic rewiring via CD31-CD38 interactions promotes growth and drug-resistance in multiple myeloma.

|Nov 27, 2025
Sequencing BCMA- and GPRC5D-targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network.

Niels W C J van de Donk, Philippe Moreau, Jesus F San-Miguel

|Nov 03, 2025
Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma.

M R Seefat, D G J Cucchi, L van Boven

|Oct 07, 2025
Immune signatures in older patients with newly diagnosed multiple myeloma are associated with survival outcomes of first-line therapy irrespective of frailty levels.

Wassilis S C Bruins, Febe Smits, Carolien Duetz

Pageof 2

Frequent Collaborators

6 joint publications

Niels W C J van de Donk

3 joint publications

Tuna Mutis

3 joint publications

Wassilis S C Bruins

2 joint publications

Kazimierz Groen